Stay updated on Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.

Latest updates to the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s footer/version indicator was updated from revision v3.5.2 to v3.5.3, reflecting a site software release rather than a change to the clinical study information.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision version updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check63 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check91 days agoChange DetectedFooter updated to Revision: v3.4.2 and prior notice Revision: v3.4.1 removed; these are editorial changes that do not affect study information or site functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check98 days agoChange DetectedAdded a government funding lapse notice and open-status disclaimer; Updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.